Search Results

You are looking at 121 - 130 of 503 items for :

  • "pathology" x
  • Refine by Access: All x
Clear All
Full access

Justin Famoso, Gerald Lemole, Srinath Sundararajan, and Baldassarre Stea

residual tumor remaining postoperatively measuring 2.9 × 2.6 × 2.4 cm on MRI ( Figure 1B ). Gross pathology revealed a dark red-brown friable mass. Microscopic evaluation showed nests of pleomorphic cells with hyperchromatic nuclei and melanotic pigment

Full access

Douglas E. Wood

resources in radiology, pulmonary medicine, thoracic surgery, and pathology, along with a disciplined and multidisciplinary approach to nodule management. In the NLST, 96% of lung nodules found were ultimately determined to be false-positives, and 24% of

Full access

Srinivas K. Tantravahi, and Theresa L. Werner

tobacco, alcohol, or illicit drugs. In June 2011 she underwent laparoscopic total hysterectomy, bilateral salpingo-oophorectomy, and pelvic and para-aortic lymphadenectomy. Pathology revealed FIGO grade 1–2 endometrioid adenocarcinoma measuring 4.2 × 3

Full access

Francois G. El Kamar and Lauren E. Abrey

Paulus W . Classification, pathogenesis and molecular pathology of primary CNS lymphomas . J Neurooncol 1999 ; 43 : 203 – 208 . 3 Schlegel U Schmidt-Wolf IG Deckert M . Primary CNS lymphoma: clinical presentation, pathological

Full access

Daniel L. Hertz and Vaibhav Sahai

.1016/S1470-2045(18)30686-7 15. Sepulveda AR , Hamilton SR , Allegra CJ , . Molecular biomarkers for the evaluation of colorectal cancer: guideline from the American Society for Clinical Pathology, College of American Pathologists, Association

Full access

Presenter: Sandy Srinivas

compared findings with biopsies. 4 Cohort A included 268 men with high-risk prostate cancer treated with 18 F-DCFPyL (safety set); of these, 252 underwent PET/CT imaging and had evaluable surgical pathology (evaluable set). Cohort B comprised 117 men with

Full access

NCCN Guidelines Insights: Breast Cancer, Version 3.2018

Featured Updates to the NCCN Guidelines

Matthew P. Goetz, William J. Gradishar, Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Kimberly H. Allison, Sarah L. Blair, Harold J. Burstein, Chau Dang, Anthony D. Elias, William B. Farrar, Sharon H. Giordano, Lori J. Goldstein, Steven J. Isakoff, Janice Lyons, P. Kelly Marcom, Ingrid A. Mayer, Meena S. Moran, Joanne Mortimer, Ruth M. O'Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth C. Reed, Hope S. Rugo, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, Melinda L. Telli, John H. Ward, Jessica S. Young, Dorothy A. Shead, and Rashmi Kumar

medical oncology, surgical oncology, radiation oncology, pathology, reconstructive surgery, and patient advocacy. In a recent version of these guidelines, the NCCN Breast Cancer Panel included updated recommendations for the use of multigene assays to

Full access

Agda Karina Eterovic, Ossama M. Maher, Joya Chandra, Ken Chen, Jason Huse, and Wafik Zaky

posterior fossa masses was performed by members of the Division of Pathology and Laboratory Medicine. Immunohistochemical studies that are pertinent to neuroblastoma and medulloblastoma tumors were used, including CD57 and neurofilaments. DNA Sequencing

Full access

Anirban Maitra

strongly support a pancreatic primary. A robust line of communication between the oncology, radiology, and pathology teams is critical for ensuring an accurate diagnosis in such cases. References 1. Rahib L Smith BD Aizenberg R . Projecting

Full access

Jeremy Matloff, Aimee Lucas, Alexandros D. Polydorides, and Steven H. Itzkowitz

proteins has become a reasonable surrogate for formal MSI testing. This technique, which can be performed in most pathology laboratories, involves staining tumors with antibodies directed against MLH1, MSH2, PMS2, and MSH6 proteins to evaluate loss or